BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 12794826)

  • 1. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
    Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
    Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
    Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
    J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
    Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis.
    Kobayashi T; Notoya K; Nakamura A; Akimoto K
    Inflamm Res; 2005 Jun; 54(6):249-55. PubMed ID: 15973508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].
    Hu H; Zhang L; Li B; Zhang Y; Liu X; Tian F; Cheng T; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Dec; 23(12):1474-81. PubMed ID: 20073314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
    Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
    Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
    Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
    J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
    Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
    J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes.
    Wen ZH; Tang CC; Chang YC; Huang SY; Hsieh SP; Lee CH; Huang GS; Ng HF; Neoh CA; Hsieh CS; Chen WF; Jean YH
    Osteoarthritis Cartilage; 2010 Sep; 18(9):1192-202. PubMed ID: 20510383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
    Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
    Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
    Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
    Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular injection of the selective cyclooxygenase-2 inhibitor meloxicam (Mobic) reduces experimental osteoarthritis and nociception in rats.
    Wen ZH; Tang CC; Chang YC; Huang SY; Chen CH; Wu SC; Hsieh SP; Hsieh CS; Wang KY; Lin SY; Lee HL; Lee CH; Kuo HC; Chen WF; Jean YH
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1976-86. PubMed ID: 24084190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.